Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cyproheptadine 2mg/5ml oral liquid
0304010K0AAADAD
|
Cyproheptadine hydrochloride | Cyproheptadine hydrochloride | Respiratory System | No data available |
|
Cyproheptadine 4mg/5ml oral liquid
0304010K0AAAFAF
|
Cyproheptadine hydrochloride | Cyproheptadine hydrochloride | Respiratory System | No data available |
|
Cyproterone 100mg/5ml oral liquid
0803042E0AAADAD
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyproterone 10mg tablets
0604020D0AAABAB
|
Cyprote acetate (Male Hormone) | Cyproterone acetate | Endocrine System | No data available |
|
Cyproterone 150mg/5ml oral liquid
0803042E0AAAHAH
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyproterone 25mg/5ml oral liquid
0803042E0AAAEAE
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyproterone 2mg capsules
1306020D0AAACAC
|
Cyprote acetate (Acne) | Cyproterone acetate | Skin | No data available |
|
Cyproterone 2mg/5ml oral suspension
0803042E0AAAIAI
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyproterone 50mg/5ml oral suspension
0803042E0AAAFAF
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyramza 100mg/10ml concentrate for inf vials
0801050BZBBAAAA
|
Cyramza | Ramucirumab | Malignant Disease and Immunosuppression | No data available |
|
Cyramza 500mg/50ml concentrate for inf vials
0801050BZBBABAB
|
Cyramza | Ramucirumab | Malignant Disease and Immunosuppression | No data available |
|
Cystagon 50mg capsules
0908010E0BBAAAA
|
Cystagon | Mercaptamine | Nutrition and Blood | No data available |
|
Cystemme effervescent granules sachets
0704030J0BDAAAI
|
Cystemme | Sodium citrate | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Cysticide 500mg tablets
0505050P0BEAAAB
|
Cysticide | Praziquantel | Infections | No data available |
|
Cystine 400mg capsules
0908010AIAAACAC
|
Cystine | Cystine | Nutrition and Blood | No data available |
|
Cystine 500mg capsules
0908010AIAAABAB
|
Cystine | Cystine | Nutrition and Blood | No data available |
|
Cystine 500mg oral powder sachets
0913213A0AAADAD
|
Powder single L-amino acid supplement (0913213) | Powder single L-amino acid supplement (0913213) | Nutrition and Blood | No data available |
|
Cystine 50mg capsules
0908010AIAAAAAA
|
Cystine | Cystine | Nutrition and Blood | No data available |
|
Cystine oral powder
0913445A0AAAHAH
|
Pdr disc/non ACBS single L-amino acid supplement (0913445) | Pdr disc/non ACBS single L-amino acid supplement (0913445) | Nutrition and Blood | No data available |
|
Cystitis Relief 4g gran for soln sachets (Alliance)
0704030J0BKAAAI
|
Unichem Cystitis | Sodium citrate | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Cystitis Relief effervescent tablets
070403000BPBEA0
|
Proprietary compound preparation BNF 0704030 | Other urological pain preparations | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Cysto-Care drainable night drainage bag
22601006050
|
Cysto-Care drainable night drainage bag | Night Drainage Bags | Incontinence Appliances | No data available |
|
Cystrin 3mg tablets
0704020J0BBAAAB
|
Cystrin | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Cystrin 5mg tablets
0704020J0BBABAC
|
Cystrin | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Cytacon 35micrograms/5ml syrup
0901020D0BCABAG
|
Cytacon | Cyanocobalamin | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.